These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23117172)

  • 1. Synthesis and SAR study of 4,5-diaryl-1H-imidazole-2(3H)-thione derivatives, as potent 15-lipoxygenase inhibitors.
    Assadieskandar A; Amini M; Salehi M; Sadeghian H; Alimardani M; Sakhteman A; Nadri H; Shafiee A
    Bioorg Med Chem; 2012 Dec; 20(24):7160-6. PubMed ID: 23117172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors.
    Jabbari A; Davoodnejad M; Alimardani M; Assadieskandar A; Sadeghian A; Safdari H; Movaffagh J; Sadeghian H
    Bioorg Med Chem; 2012 Sep; 20(18):5518-26. PubMed ID: 22917856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and SAR studies of 4-allyoxyaniline amides as potent 15-lipoxygensae inhibitors.
    Seyedi SM; Eshghi H; Jafari Z; Attaran N; Sadeghian H; Saberi MR; Riazi MM
    Bioorg Med Chem; 2009 Feb; 17(4):1614-22. PubMed ID: 19157886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
    Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
    Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF; Philoppes JN; Rárová L
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors.
    Iranshahi M; Jabbari A; Orafaie A; Mehri R; Zeraatkar S; Ahmadi T; Alimardani M; Sadeghian H
    Eur J Med Chem; 2012 Nov; 57():134-42. PubMed ID: 23047230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase.
    Dianat S; Moghimi S; Mahdavi M; Nadri H; Moradi A; Firoozpour L; Emami S; Mouradzadegun A; Shafiee A; Foroumadi A
    J Enzyme Inhib Med Chem; 2016; 31(sup3):205-209. PubMed ID: 27424740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-1, C-3 substituted indoles as 5-LOX inhibitors--in vitro enzyme immunoaasay, mass spectral and molecular docking investigations.
    Singh P; Pooja
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1433-7. PubMed ID: 23337599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazo[2,1-b]thiazole derivatives as new inhibitors of 15-lipoxygenase.
    Tehrani MB; Emami S; Asadi M; Saeedi M; Mirzahekmati M; Ebrahimi SM; Mahdavi M; Nadri H; Moradi A; Moghadam FH; Farzipour S; Vosooghi M; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Nov; 87():759-64. PubMed ID: 25310714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
    ElBordiny HS; El-Miligy MM; Kassab SE; Daabees H; Mohamed Ali WA; Abdelhamid Mohamed El-Hawash S
    Eur J Med Chem; 2018 Feb; 145():594-605. PubMed ID: 29339254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR comparative studies of 2-allyl-4-methoxy-1-alkoxybenzenes as 15-lipoxygenase inhibitors.
    Sadeghian H; Seyedi SM; Attaran N; Jabbari A; Jafari Z
    J Enzyme Inhib Med Chem; 2011 Apr; 26(2):238-44. PubMed ID: 20939767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
    Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
    Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure based drug design, synthesis and evaluation of 4-(benzyloxy)-1-phenylbut-2-yn-1-ol derivatives as 5-lipoxygenase inhibitors.
    Reddy NP; Chandramohan Reddy T; Aparoy P; Achari C; Sridhar PR; Reddanna P
    Eur J Med Chem; 2012 Jan; 47(1):351-9. PubMed ID: 22118829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase.
    Shaari K; Suppaiah V; Wai LK; Stanslas J; Tejo BA; Israf DA; Abas F; Ismail IS; Shuaib NH; Zareen S; Lajis NH
    Bioorg Med Chem; 2011 Nov; 19(21):6340-7. PubMed ID: 21958738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of eugenol derivatives, as potent 15-lipoxygenase inhibitors.
    Sadeghian H; Seyedi SM; Saberi MR; Arghiani Z; Riazi M
    Bioorg Med Chem; 2008 Jan; 16(2):890-901. PubMed ID: 17998164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dicoumarol derivatives: Green synthesis and molecular modelling studies of their anti-LOX activity.
    Simijonović D; Vlachou EE; Petrović ZD; Hadjipavlou-Litina DJ; Litinas ΚE; Stanković N; Mihović N; Mladenović MP
    Bioorg Chem; 2018 Oct; 80():741-752. PubMed ID: 30077781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors.
    Reddy NP; Aparoy P; Reddy TC; Achari C; Sridhar PR; Reddanna P
    Bioorg Med Chem; 2010 Aug; 18(16):5807-15. PubMed ID: 20667741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors.
    Mahdavi M; Shirazi MS; Taherkhani R; Saeedi M; Alipour E; Moghadam FH; Moradi A; Nadri H; Emami S; Firoozpour L; Shafiee A; Foroumadi A
    Eur J Med Chem; 2014 Jul; 82():308-13. PubMed ID: 24927051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of imidazole 5-lipoxygenase inhibitors and selection and synthesis of a development candidate.
    Mano T; Stevens RW; Ando K; Kawai M; Kawamura K; Nakao K; Okumura Y; Okumura T; Sakakibara M; Miyamoto K; Tamura T
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):965-73. PubMed ID: 16079529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.